Quest Diagnostics raised its full-year profit forecast after second-quarter results beat estimates, supported by stronger demand for routine diagnostic testing. The guidance increase signals improving fundamentals rather than a one-off beat, likely providing a modest positive catalyst for the stock.
Quest Diagnostics raised its full-year profit forecast after second-quarter results beat estimates, supported by stronger demand for routine diagnostic testing. The guidance increase signals improving fundamentals rather than a one-off beat, likely providing a modest positive catalyst for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.40
Ticker Sentiment
